Growth Metrics

Gilead Sciences (GILD) Amortizatization of Intangibles (2009 - 2026)

Gilead Sciences posted quarterly Amortizatization of Intangibles of $596.0 million for Q1 2026, down 0.5% year-on-year from $599.0 million in Q1 2025, and little changed on a QoQ basis from $597.0 million in Q4 2025.

Gilead Sciences (GILD) has 18 years of Amortizatization of Intangibles data on file, last reported at $596.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles fell 0.5% year-over-year to $596.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 billion (changed 0.08% YoY), and the FY2025 full-year result was $2.4 billion, changed 0.17% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $596.0 million, roughly flat from $597.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $599.0 million in Q1 2025 and bottomed at $445.0 million in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $596.0 million (2024), against an average of $558.3 million.
  • The widest annual swing landed in 2023, when Amortizatization of Intangibles soared 34.38%; it then dropped 0.5% in 2026.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $445.0 million in 2022, then surged by 34.16% to $597.0 million in 2023, then rose by 0.17% to $598.0 million in 2024, then declined by 0.17% to $597.0 million in 2025, then dropped by 0.17% to $596.0 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $596.0 million (Q1 2026), $597.0 million (Q4 2025), and $596.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 1.70 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 931.00 Mn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 596.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 596.00 Mn
Mar 31, 2026 596.00 Mn
Dec 31, 2025 597.00 Mn
Dec 31, 2025 597.00 Mn
Sep 30, 2025 596.00 Mn
Sep 30, 2025 596.00 Mn
Jun 30, 2025 598.00 Mn
Jun 30, 2025 598.00 Mn
Mar 31, 2025 599.00 Mn
Mar 31, 2025 599.00 Mn
Dec 31, 2024 598.00 Mn
Dec 31, 2024 598.00 Mn
Sep 30, 2024 596.00 Mn
Sep 30, 2024 596.00 Mn
Jun 30, 2024 596.00 Mn
Jun 30, 2024 596.00 Mn
Mar 31, 2024 596.00 Mn
Mar 31, 2024 596.00 Mn
Dec 31, 2023 597.00 Mn
Dec 31, 2023 597.00 Mn
Sep 30, 2023 598.00 Mn
Sep 30, 2023 598.00 Mn
Jun 30, 2023 598.00 Mn
Jun 30, 2023 598.00 Mn
Mar 31, 2023 546.00 Mn
Mar 31, 2023 546.00 Mn
Dec 31, 2022 445.00 Mn
Dec 31, 2022 445.00 Mn
Sep 30, 2022 445.00 Mn
Sep 30, 2022 445.00 Mn
Jun 30, 2022 445.00 Mn
Jun 30, 2022 445.00 Mn
Mar 31, 2022 445.00 Mn
Mar 31, 2022 445.00 Mn
Dec 31, 2021 445.00 Mn
Dec 31, 2021 445.00 Mn
Sep 30, 2021 441.00 Mn
Sep 30, 2021 441.00 Mn
Jun 30, 2021 440.00 Mn
Jun 30, 2021 440.00 Mn
Mar 31, 2021 395.00 Mn
Mar 31, 2021 395.00 Mn
Dec 31, 2020 348.00 Mn
Dec 31, 2020 348.00 Mn
Sep 30, 2020 282.00 Mn
Sep 30, 2020 282.00 Mn
Jun 30, 2020 281.00 Mn
Jun 30, 2020 281.00 Mn
Mar 31, 2020 281.00 Mn
Mar 31, 2020 281.00 Mn
Dec 31, 2019 281.00 Mn
Dec 31, 2019 281.00 Mn
Sep 30, 2019 281.00 Mn
Sep 30, 2019 281.00 Mn
Jun 30, 2019 288.00 Mn
Jun 30, 2019 288.00 Mn
Mar 31, 2019 299.00 Mn
Mar 31, 2019 299.00 Mn
Dec 31, 2018 301.00 Mn
Dec 31, 2018 301.00 Mn
Sep 30, 2018 301.00 Mn
Sep 30, 2018 301.00 Mn
Jun 30, 2018 300.00 Mn
Jun 30, 2018 300.00 Mn
Mar 31, 2018 301.00 Mn
Mar 31, 2018 301.00 Mn
Dec 31, 2017 319.00 Mn
Dec 31, 2017 319.00 Mn
Sep 30, 2017 245.00 Mn
Sep 30, 2017 245.00 Mn
Jun 30, 2017 244.00 Mn
Jun 30, 2017 244.00 Mn
Mar 31, 2017 245.00 Mn
Mar 31, 2017 245.00 Mn
Dec 31, 2016 244.00 Mn
Dec 31, 2016 244.00 Mn
Sep 30, 2016 255.00 Mn
Sep 30, 2016 255.00 Mn
Jun 30, 2016 241.00 Mn
Jun 30, 2016 241.00 Mn
Mar 31, 2016 241.00 Mn
Mar 31, 2016 241.00 Mn
Dec 31, 2015 233.00 Mn
Dec 31, 2015 233.00 Mn
Sep 30, 2015 237.00 Mn
Sep 30, 2015 237.00 Mn
Jun 30, 2015 235.00 Mn
Jun 30, 2015 235.00 Mn
Mar 31, 2015 232.00 Mn
Mar 31, 2015 232.00 Mn
Dec 31, 2014 244.00 Mn
Dec 31, 2014 244.00 Mn
Sep 30, 2014 227.00 Mn
Sep 30, 2014 227.00 Mn
Jun 30, 2014 237.00 Mn
Jun 30, 2014 237.00 Mn
Mar 31, 2014 217.00 Mn
Mar 31, 2014 217.00 Mn
Dec 31, 2013 101.30 Mn
Dec 31, 2013 101.30 Mn
Sep 30, 2013 43.29 Mn
Sep 30, 2013 43.29 Mn
Jun 30, 2013 47.06 Mn
Jun 30, 2013 47.06 Mn
Mar 31, 2013 50.35 Mn
Mar 31, 2013 50.35 Mn
Dec 31, 2012 50.91 Mn
Dec 31, 2012 50.91 Mn
Sep 30, 2012 50.45 Mn
Sep 30, 2012 50.45 Mn
Jun 30, 2012 47.19 Mn
Jun 30, 2012 47.19 Mn
Mar 31, 2012 46.46 Mn
Mar 31, 2012 46.46 Mn
Dec 31, 2011 54.47 Mn
Dec 31, 2011 54.47 Mn
Sep 30, 2011 55.80 Mn
Sep 30, 2011 55.80 Mn
Jun 30, 2011 57.15 Mn
Jun 30, 2011 57.15 Mn
Mar 31, 2011 62.63 Mn
Mar 31, 2011 62.63 Mn
Dec 31, 2010 59.65 Mn
Dec 31, 2010 59.65 Mn
Sep 30, 2010 53.06 Mn
Sep 30, 2010 53.06 Mn
Jun 30, 2010 42.89 Mn
Jun 30, 2010 42.89 Mn
Mar 31, 2010 42.63 Mn
Mar 31, 2010 42.63 Mn
Dec 31, 2009 43.86 Mn
Dec 31, 2009 43.86 Mn
Sep 30, 2009 41.57 Mn
Sep 30, 2009 41.57 Mn
Jun 30, 2009 37.53 Mn
Jun 30, 2009 37.53 Mn
Mar 31, 2009 25.43 Mn
Mar 31, 2009 25.43 Mn